Silvana Lobo

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Variant-specific functional effects of CTNNA1 in a humanized Drosophila model.

Variant-specific functional effects of CTNNA1 in a humanized Drosophila model.

Journal: European journal of human genetics : EJHG

Published: July 14, 2025

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.

Journal: Gut

Published: December 16, 2024

A protocol for karyotyping and genetic editing of induced pluripotent stem cells with homology-directed repair mediated CRISPR/Cas9.

A protocol for karyotyping and genetic editing of induced pluripotent stem cells with homology-directed repair mediated CRISPR/Cas9.

Journal: Biology methods & protocols

Published: November 13, 2024

Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.

Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.

Journal: The Lancet. Oncology

Published: July 17, 2022

First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants.

First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants.

Journal: Journal of medical genetics

Published: June 03, 2022

Cancer predisposition and germline CTNNA1 variants.

Cancer predisposition and germline CTNNA1 variants.

Journal: European journal of medical genetics

Published: April 07, 2021

Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells.

Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells.

Journal: Cancers

Published: July 03, 2020

Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence.

Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 27, 2019

A posttranslational modification in histones as prognostic/predictive marker in Estrogen-Positive Breast Cancer: PS209.

A posttranslational modification in histones as prognostic/predictive marker in Estrogen-Positive Breast Cancer: PS209.

Journal: Porto biomedical journal

Published: September 01, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026